Clinical relevance of CDH1 and CDH13 DNA-methylation in serum of cervical cancer patients

International Journal of Molecular Sciences

Volumn 13, Issue 7, 2012, Pages 8353-8363

  Abudukadeer, Abida ^a   Bakry, Rania ^b   Goebel, Georg ^c   Mutz Dehbalaie, Irene ^c   Widschwendter, Andreas ^c   Bonn, Günther K ^b   Fiegl, Heidi ^c  

^a Medical University of Xinjiang   (China)

^b UNIVERSITY OF INNSBRUCK   (Austria)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Cancer biomarker; DNA methylation; Epigenomics; Prognosis; Translational cancer research

Indexed keywords

CADHERIN; H CADHERIN; UNCLASSIFIED DRUG; UVOMORULIN; CDH1 PROTEIN, HUMAN; DNA; H-CADHERIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER PROGNOSIS; CANCER RELAPSE; CDH1 GENE; CDH13 GENE; CLINICAL ARTICLE; CONTROLLED STUDY; DEATH; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; DNA METHYLATION; FEMALE; HUMAN; INTERMETHOD COMPARISON; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; RECURRENCE FREE SURVIVAL; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CANCER; BLOOD; GENETICS; KAPLAN MEIER METHOD; MALE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PROGNOSIS; PROMOTER REGION; TUMOR RECURRENCE; UTERINE CERVIX TUMOR;

CADHERINS; DNA METHYLATION; DNA, NEOPLASM; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROMOTER REGIONS, GENETIC; UTERINE CERVICAL NEOPLASMS;

EID: 84864373956     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms13078353     Document Type: Article

References (21)

1. Tost, J. DNA methylation: An introduction to the biology and the disease-associated changes of a promising biomarker. Mol. Biotechnol. 2010, 44, 71-81.
2. Yang, H.J.; Liu, V.W.S.; Wang, Y.; Chan, K.Y.K.; Tsang, P.C.K.; Khoo, U.S.; Cheung, A.N.Y.; Ngan, H.Y.S. Detection of hypermethylated genes in tumor and plasma of cervical cancer patients. Gynecol. Oncol. 2004, 93, 435-440.
3. Widschwendter, A.; Gattringer, C.; Ivarsson, L.; Fiegl, H.; Schneitter, A.; Ramoni, A.; Müller, H.M.; Wiedemair, A.; Jerabek, S.; Müller-Holzner, E.; et al. Analysis of aberrant DNA methylation and human papillomavirus DNA in cervico-vaginal specimens to detect invasive cervical cancer and its precursors. Clin. Cancer Res. 2004, 10, 3396-3400.
4. Widschwendter, A.; Müller, H.M.; Fiegl, H.; Ivarsson, L.; Wiedemair, A.; Müller-Holzner, E.; Goebel, G.; Marth, C.; Widschwendter, M. DNA methylation in serum and tumors of cervical cancer patients. Clin. Cancer Res. 2004, 10, 565-571.
5. Wu, T.; Giovannucci, E.; Welge, J.; Mallick, P.; Tang, W.Y.; Ho, S.M. Measurement of GSTP1 promoter methylation in body fluids may complement PSA screening: A meta-analysis. Br. J. Cancer 2011, 105, 65-73.
6. Warren, J.D.; Xiong, W.; Bunker, A.M.; Vaughn, C.P.; Furtado, L.V.; Roberts, W.L.; Fang, J.C.; Samowitz, W.S.; Heichman, K.A. Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer. BMC Med. 2011, 9, 133.
7. Ng, E.K.; Leung, C.P.; Shin, V.Y.; Wong, C.L.; Ma, E.S.; Jin, H.C.; Chu, K.M.; Kwong, A. Quantitative analysis and diagnostic significance of methylated SLC19A3 DNA in the plasma of breast and gastric cancer patients. PLoS One 2011, 6, e22233.
8. Liggett, T.E.; Melnikov, A.; Yi, Q.; Replogle, C.; Hu, W.; Rotmensch, J.; Kamat, A.; Sood, A.K.; Levenson, V. Distinctive DNA methylation patterns of cell-free plasma DNA in women with malignant ovarian tumors. Gynecol. Oncol. 2011, 120, 113-120.
9. Ostrow, K.L.; Hoque, M.O.; Loyo, M., Brait, M.; Greenberg, A.; Siegfried, J.M.; Grandis, J.R.; Gaither Davis, A.; Bigbee, W.L.; Rom, W.; et al. Molecular analysis of plasma DNA for the early detection of lung cancer by quantitative methylation-specific PCR. Clin. Cancer Res. 2010, 16, 3463-3472.
10. Oda, H.; Takeichi, M. Evolution: Structural and functional diversity of cadherin at the adherens junction. J. Cell Biol. 2011, 193, 1137-1146.
11. Kuphal, S.; Martyn, A.C.; Pedley, J.; Crowther, L.M.; Bonazzi, V.F.; Parsons, P.G.; Bosserhoff, A.K.; Hayward, N.K.; Boyle, G.M. H-cadherin expression reduces invasion of malignant melanoma. Pigment Cell Melanoma Res. 2009, 22, 296-306.
12. Ling, Z.Q.; Li, P.; Ge, M.H.; Zhao, X.; Hu, F.J.; Fang, X.H.; Dong, Z.M.; Mao, W.M. Hypermethylation-modulated down-regulation of CDH1 expression contributes to the progression of esophageal cancer. Int. J. Mol. Med. 2011, 27, 625-635.
13. Chen, C.L.; Liu, S.S.; Ip, S.-M.; Wong, L.C.; Ngan, H.Y.S. E-cadherin expression is silenced by DNA methylation in cervical cancer cell lines and tumours. Eur. J. Cancer 2003, 39, 517-523.
14. Sebova, K.; Zmetakova, I.; Bella, V.; Kajo, K.; Stankovicova, I.; Kajabov, V.; Krivulcik, T.; Lasabova, Z.; Tomka, M.; Galbavy, S.; et al. RASSF1A and CDH1 hypermethylation as potential epimarkers in breast cancer. Cancer Biomark. 2011-2012, 10, 13-26.
15. Widschwendter, A.; Ivarsson, L.; Blassnig, A.; Müller, H.M.; Fiegl, H.; Wiedemair, A.; Müller-Holzner, E.; Goebel, G.; Marth, C.; Widschwendter, M. CDH1 and CDH13 methylation in serum is an independent prognostic marker in cervical cancer patients. Int. J. Cancer 2004, 109, 163-166.
16. Graflund, M.; Sorbe, B.; Hussein, A.; Bryne, M.; Karlsson, M. The prognostic value of histopathologic grading parameters and microvessel density in patients with early squamous cell carcinoma of the uterine cervix. Int. J. Gynecol. Cancer 2002, 12, 32-41.
17. Metindir, J.; Bilir, G. Prognostic factors affecting disease-free survival in early-stage cervical cancer patients undergoing radical hysterectomy and pelvic-paraaortic lymphadenectomy. Eur. J. Gynaecol. Oncol. 2007, 28, 28-32.
18. Kang, S.; Kim, J.W.; Kang, G.H.; Park, N.H.; Song, Y.S.; Kang, S.B.; Lee, H.P. Polymorphism in folate-and methionine-metabolizing enzyme and aberrant CpG island hypermethylation in uterine cervical cancer. Gynecol. Oncol. 2005, 96, 173-180.
19. Narayan, G.; Arias-Pulido, H.; Koul, S.; Vargas, H.; Zhang, F.F.; Villella, J.; Schneider, A.; Terry, M.B.; Mansukhani, M.; Murty, V.V. Frequent promoter methylation of CDH1, DAPK, RARB, and HIC1 genes in carcinoma of cervix uteri: Its relationship to clinical outcome. Mol. Cancer 2003, 2, 24.
20. Wentzensen, N.; Sherman, M.E.; Schiffman, M.; Wang, S.S. Utility of methylation markers in cervical cancer early detection: Appraisal of the state-of-the-science. Gynecol. Oncol. 2009, 112, 293-299.
21. Eads, C.A.; Danenberg, K.D.; Kawakami, K.; Saltz, L.B.; Blake, C.; Shibata, D.; Danenberg, P.V.; Laird, P.W. MethyLight: A high-throughput assay to measure DNA methylation. Nucleic Acids Res. 2000, 28, e32.